Kolon Life Science Inc. (KOSDAQ: 102940)
South Korea
· Delayed Price · Currency is KRW 19,950
+530 (2.73%)
Oct 11, 2024, 9:00 AM KST
Kolon Life Science Revenue
Kolon Life Science had revenue of 40.05B KRW in the quarter ending June 30, 2024, with 26.74% growth. This brings the company's revenue in the last twelve months to 140.27B, down -0.68% year-over-year. In the year 2023, Kolon Life Science had annual revenue of 124.64B, down -22.86%.
Revenue (ttm)
140.27B
Revenue Growth
-0.68%
P/S Ratio
1.63
Revenue / Employee
333.19M
Employees
421
Market Cap
247.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 124.64B | -36.94B | -22.86% |
| Dec 31, 2022 | 161.58B | -3.90B | -2.36% |
| Dec 31, 2021 | 165.49B | 36.07B | 27.87% |
| Dec 31, 2020 | 129.41B | -19.13B | -12.88% |
| Dec 31, 2019 | 148.54B | 7.29B | 5.16% |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
| Dec 31, 2010 | Pro | Pro | Pro |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition